Riddhidev Banerjee

De novo Design and in-silico Studies of Coumarin Derivatives as Inhibitors of Cyclin Dependent Kinase-2 1

S. Chander, M. Coumar, Paritosh Shukla, 2017 .

Potential SARS-CoV-2 main protease inhibitors

L. Perera, L. Tillekeratne, Riddhidev Banerjee, 2020, Drug Discovery Today.